Anna Axelsson Raja
ORCID: 0000-0001-8665-3309Also affiliated with Copenhagen University Hospital, Rigshospitalet
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Finn Stener Jørgensen, Olav Bjørn Petersen, Helle Zingenberg, Sofie Dannesbo, Anna Axelsson Raja +5 more
Papers
Driven by 5 papers — median percentile 22. Top paper: “Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial”.
Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka, Harry M. Lever +40 more
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model
Hiroko Wakimoto, Daniel M. DeLaughter, Daniel Reichart, Joshua M. Gorham, David A. Conner +19 more
Danielle S. Burstein, Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka +19 more
Finn Stener Jørgensen, Olav Bjørn Petersen, Helle Zingenberg, Sofie Dannesbo, Anna Axelsson Raja +5 more
Mitra Mastali, Jennifer E. Van Eyk, E. John Orav, Christoffer Rasmus Vissing, Sharlene M. Day +27 more